Because TEMs are reported as being one of the most potent cell types in supporting vascularization, and because we found that CSF1 up-regulates Tie2 receptor expression on CD14+ human monocytes, we asked if CSF1 treatment would expand the number of tumor TEMs and alter angiogenesis in a mouse model of breast cancer. This evidence concerns the gene CSF1 and breast cancer.